Literature DB >> 11416729

Efavirenz plasma concentrations and efficiency.

L F López-Cortés, A de Alarcón, P Viciana.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11416729     DOI: 10.1097/00002030-200106150-00022

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients.

Authors:  Verena Gounden; Chantal van Niekerk; Tracy Snyman; Jaya A George
Journal:  AIDS Res Ther       Date:  2010-08-19       Impact factor: 2.250

2.  Evaluation of an immunoassay for determination of plasma efavirenz concentrations in resource-limited settings.

Authors:  Alemseged Abdissa; Lubbe Wiesner; Helen McIlleron; Henrik Friis; Ase Bengård Andersen; Pernille Kaestel
Journal:  J Int AIDS Soc       Date:  2014-06-05       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.